Ono Pharmaceutical Co Ltd - Company Profile
Powered by
All the data and insights you need on Ono Pharmaceutical Co Ltd in one report.
- Save hours of research time and resources with
our up-to-date Ono Pharmaceutical Co Ltd Strategy Report
- Understand Ono Pharmaceutical Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Ono Pharmaceutical Catalyst Calendar
Proactively evaluate Ono Pharmaceutical Co Ltd’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Ono Pharmaceutical Catalyst Calendar data
Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
---|---|---|---|---|---|---|---|
27 Sep 2019 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
16 Sep 2019 | Phase III Trial Initiation | Bristol-Myers Squibb Co; Ono Pharmaceutical Co Ltd | 4528; BMY | ipilimumab; nivolumab | Oncology | Hepatocellular Carcinoma; Liver Cancer | Clinical Trial Registry |
01 Sep 2019 | Phase III Trial Completion | Ono Pharmaceutical Co Ltd; Seikagaku Corp | 4528; 4548 | diclofenac etalhyaluronate sodium SR | Musculoskeletal Disorders | Osteoarthritis | Clinical Trial Registry |
30 Aug 2019 | Phase I Trial Completion | Ono Pharmaceutical Co Ltd | 4528 | ONO-5788 | Hormonal Disorders | Acromegaly | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer